ANDA 212809, held by Ajanta Pharma Ltd. Captopril.
As of Nov 13, 2026, ANDA 212809 (Captopril), held by Ajanta Pharma Ltd, was first approved by FDA on Dec 13, 2019, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 13, 2019 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
